| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |